Lucknow (Uttar Pradesh): Pratap Chandra, a local resident from UP's Lucknow had filed a complaint against Adar Poonawalla, the Chief Executive Officer of the Serum Institute of India and seven others, alleging that despite having taken the Covid-19 vaccine (Covishield) he did not develop antibodies.
Hence the complainant filed a case at the Ashiyana Police Station demanding trial against Poonawalla as well as Director of Drugs Controller General of India Director (DCGI) - Central Drugs Standard Control Organisation (CDSCO), Representative of World Health Organization (WHO), Joint Secretary in the Ministry of Health and Family Welfare, ICMR Director, Director of National Health Mission Uttar Pradesh and Director of Govind Hospital And Research Centre, Lucknow.
Taking cognizance of the matter, a Lucknow court sought a report from the Ashiyana Police Station. The next hearing of the case will be held on July 2.
Read: ‘Hope to resolve soon’: Adar Poonawalla on travel issues faced by Covishield takers
The application states that the plaintiff was administered the first dose of Covishield vaccine on April 8, 2021, at the Govind Hospital and the second dose was to be administered after 28 days. However, during this time the government had extended the time gap for the second dose by 12 weeks. Meanwhile, Chandra who wasn't feeling well after being inoculated with the first dose undertook a 'COVID-19 Antibody GT Test' which basically identifies whether a person was Covid positive in the past, and has developed antibodies against the virus.
Chandra learnt that his body did not develop any antibodies and that his platelet count was reduced by more than half, thereby making him more vulnerable to the deadly infection. The plaintiff says that his life has been played with, in the name of vaccines and that he can die at any time.
